Navigation Links
Omeros Corporation Reports Second Quarter 2012 Financial Results
Date:8/7/2012

SEATTLE, Aug. 7, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2012.

Financial ResultsTotal operating expenses for the quarter ended June 30, 2012 were $9.8 million compared to $6.1 million for the same period in 2011. The increase in operating expenses primarily relates to increased Phase 3 clinical trial expenses for OMS302 and OMS103HP and an increase in expenses in connection with preclinical work for Omeros' PDE10 and MASP-2 programs in preparation for their advancement into the clinic. For the quarter ended June 30, 2012, Omeros reported a net loss of $8.5 million, or $0.38 per share, compared to a net loss of $5.3 million, or $0.24 per share, for the same period in 2011.

At June 30, 2012, Omeros had cash, cash equivalents and short-term investments of $7.3 million. On July 2, 2012, Omeros completed a public offering pursuant to which it sold 3,365,854 shares of its common stock at a price of $10.25 per share for estimated net proceeds of $32.4 million. 

"Our two ongoing Phase 3 clinical trials continued to advance during the quarter – OMS302 for lens replacement procedures and OMS103HP for arthroscopic meniscectomy surgery – and we expect to report data for both in the second half of this year," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.  "We have also begun to prepare the NDA for OMS302 which, assuming positive data from the ongoing clinical trial, we expect to submit to the FDA during the first part of 2013.  Our other programs also progressed, and we plan to file an IND for our PDE10 inhibitor this quarter with an IND f
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces Discovery in MASP-2 Program
2. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
3. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
4. Omeros Prices $30 Million Public Offering of Common Stock
5. Omeros Announces Proposed Public Offering of Common Stock
6. Omeros to Present at Jefferies 2012 Global Healthcare Conference
7. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
8. Omeros to Present at Deutsche Bank Securities Health Care Conference
9. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
10. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
11. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... WASHINGTON , July 31, 2014  According to ... Medicaid Services, the 2015 average monthly Medicare Part D ... figure far lower than was originally projected, the Pharmaceutical ... Part D program continues to be a bright spot ... competing choices in each region and using cutting edge, ...
(Date:7/31/2014)... 31, 2014  ResMed Inc. (NYSE: RMD ) ... fiscal year ended June 30, 2014.  Revenue for the quarter ... 30, 2013 (a 1 percent decrease on a constant currency ... percent compared to the quarter ended June 30, 2013. Diluted ... of 22 percent compared to the quarter ended June 30, ...
(Date:7/31/2014)... , July 31, 2014  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... New York, NY Wednesday, August 13, ... Health Care Conference, New York, NY ... Accessing Live Webcasts To access the live webcasts ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Cepheid to Webcast Upcoming Financial Presentations 2
... SUNNYVALE, Calif., Feb. 28, 2011 /PRNewswire/ ... company developing innovative technologies in diabetes management, announced that ... Silicon Valley Bank and ... used to help complete clinical trials and commercialize POGO™, ...
... Feb. 28, 2011 Advanced Cell Diagnostics, Inc. ... study utilizing RNAscope™ technology to detect human papillomavirus ... head and neck cancer. HPV status determined by ... patient outcome and highly concordant with that determined ...
Cached Medicine Technology:Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation 2Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation 3ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3
(Date:8/1/2014)... Blindness is a reversible ailment these days . ... despite well-meaning efforts, still have a long way to go ... blindness that does not involve any kind of health risk ... takes the “slack” from the mainstream by providing a cure ... , Alternative health specialist Kevin Richardson actually has the ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 AAGL, ... gynecologic endoscopic surgery, is pleased to announce a ... the United States and Europe, which strongly recommends ... to surgeons an endoscopic dry lab for training ... their endoscopic surgery skills. , Endoscopy is the ...
(Date:8/1/2014)... Surftech athletes Jack Bark and Carter Graves won ... past weekend in Hawaii in commanding fashion shattering world ... were all on stock Surftech Bark Commanders. The event ... this year were treated to 6-10 foot seas and ... as well as very fast. , The win ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 iFitDress.com, a ... unveiled its new collection of 2014 silver bridesmaid ... are manufactured according to the latest fashion trends. What’s ... 15 to 55 percent off. , iFitDress.com is ... it deals in not only silver bridesmaid gowns, but ...
(Date:7/31/2014)... over the age of 65 face numerous barriers to ... against poverty and higher rates of asthma with worse ... of Annals of Allergy, Asthma and Immunology , ... Asthma and Immunology (ACAAI), outlines the challenges faced by ... to improve their care. , "Allergists want ...
Breaking Medicine News(10 mins):Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2Health News:AAGL Announces It Has Joined With Other Medical Societies to Encourage Hospitals Teaching Endoscopic Surgery to Establish Simulator Labs for Training 2Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3
... , WASHINGTON, Sept. 11 The ... and Economic Studies: , , WHO : ... Johns Hopkins University Bloomberg School of Public Health, Drexel University School ... , , WHAT : The Joint Center,s ...
... disease progression , FRIDAY, Sept. 11 (HealthDay News) -- Two ... body,s ability to repair itself when afflicted with multiple sclerosis, ... , "Most MS genetic studies have looked at disease susceptibility ... not," study author Allan Bieber, a Mayo Clinic neuroscientist, said ...
... legs as they get older? As we age it becomes harder ... and increases the likelihood of falls and fractures. New research is ... A team of Nottingham researchers has already shown that when ... young. Now they,ve found that the suppression of muscle breakdown, which ...
... oxygen-carrying component of hemoglobin, the protein that makes blood ... and energy metabolism within the cell. Heme levels are ... prevents cell growth and division; excessive amounts of heme ... Pennsylvania School of Medicine have discovered a molecular circuit ...
... , , PHOENIX, Sept. 11 ... Health Plan Arizona President Tom Lescault co-hosts "Senior Focus" every other ... producer of the "Valley Views" show, Lescault interviews local experts on ... ",Senior Focus, is about seniors, for seniors and reflective of seniors, ...
... , , , ... and Union Activism , , SILVER ... convention starting Sept. 14, AFL-CIO will honor the work of UAN,s ... work helped make workers, voices heard. , , ...
Cached Medicine News:Health News:Joint Center to Unveil Health Reform Study Providing Answers: What Is the Cost of Not Addressing Racial Health Disparities? 2Health News:Muscle: 'Hard to build, easy to lose' as you age 2Health News:Inner workings of molecular thermostat point to pathways to fight diabetes, obesity 2Health News:Inner workings of molecular thermostat point to pathways to fight diabetes, obesity 3Health News:SCAN Health Plan CEO Tom Lescault Hosts Biweekly 'Senior Focus' Show on KOY-1230AM, Seeks Input from Area Seniors 2Health News:UAN Nurse Among Political Activists To Be Honored by AFL-CIO 2
Icefire has ice crystals on the top of a cool blue iris....
This design features a solid red iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Medicine Products: